An electronic patient-reported outcome symptom monitor: the Chinese experience with rapid development of a ready-to-go symptom monitor

Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 24; no. 1; pp. 2989 - 11
Main Authors Zhang, Jingyu, Guo, Qing, Chen, Jiaojiao, Liu, Yajie, Kang, Dan, Xiang, Rumei, Shi, Jiaheng, Yang, Jinliang, Tang, Xiaojun, Nie, Yuxian, Qiu, Jingfu, Wang, Xu, Yang, Zhu, Liu, Jie, Shi, Qiuling
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 29.10.2024
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1471-2458
1471-2458
DOI10.1186/s12889-024-20518-5

Cover

Loading…
Abstract Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations. The development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM. The ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18-40 years old) than in the older group (40-67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period. Electronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations.
AbstractList Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations. The development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM. The ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18-40 years old) than in the older group (40-67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period. Electronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations.
Background Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations. Methods The development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM. Results The ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18-40 years old) than in the older group (40-67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period. Conclusions Electronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations. Keywords: COVID-19, Electronic Patient-Reported Outcome, Symptom, Electronic platform
BackgroundMonitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations.MethodsThe development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM.ResultsThe ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18–40 years old) than in the older group (40–67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period.ConclusionsElectronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations.
Abstract Background Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations. Methods The development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM. Results The ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18–40 years old) than in the older group (40–67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period. Conclusions Electronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations.
Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations.BACKGROUNDMonitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations.The development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM.METHODSThe development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM.The ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18-40 years old) than in the older group (40-67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period.RESULTSThe ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18-40 years old) than in the older group (40-67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period.Electronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations.CONCLUSIONSElectronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations.
Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and mortality rates in rapidly spreading pandemics, such as COVID-19. Therefore, during infectious disease pandemics, the rapid development of real-time symptom monitoring platforms is essential. This study aimed to explore the urgent development process of an electronic system for patient-reported outcome monitoring in emergency situations. The development of the electronic patient-reported outcome COVID-19 symptom monitoring platform (ePRO-CoV-SM) included the following steps: (1) modifying an electronic patient-reported outcome symptom-reporting platform to assess patients with COVID-19 and validating its feasibility and sensitivity for longitudinal symptom measurement; (2) updating the system to accommodate the newly emerged severe acute respiratory syndrome coronavirus 2 BA.2.2 variant; and (3) applying it in real-world settings. Literature review, expert consultation, and subject-group discussions were used to develop symptom items. Response rate and missing item rate were used as validation indicators for ePRO-CoV-SM. The ePRO-CoV-SM (2.0) consists of a core set of symptom items, a WeChat mini program, an online project design backend, a management and communication front, and a database. During the 2020 verification, the response rate of ePRO symptom monitoring reached 89.47% and the item missing rate was 0.33%, the monitoring revealed that a considerable number of asymptomatic patients were experiencing undesirable symptoms during the isolation period. In its real-world application in 2022, the response rate was 85.93% and the item missing rate was 4.84%, the monitoring found the symptom burden was higher in the younger group (18-40 years old) than in the older group (40-67 years old), and over 30% of patients reported symptoms such as cough (36.08%), dry mouth (35.67%), sleep disorders (32.27%), appetite loss (32.17%), and sputum (30.79%) during the isolation period. Electronic patient-reported outcome measurement was demonstrated to be sensitive and feasible for monitoring symptoms in patients with COVID-19. By integrating smartphone-based data collection with real-time online data transmission and secure data storage using Secure Sockets Layer encryption, an electronic platform for monitoring critical symptoms can be rapidly established in emergency situations.
ArticleNumber 2989
Audience Academic
Author Zhang, Jingyu
Wang, Xu
Kang, Dan
Yang, Jinliang
Qiu, Jingfu
Nie, Yuxian
Tang, Xiaojun
Xiang, Rumei
Guo, Qing
Liu, Jie
Chen, Jiaojiao
Shi, Qiuling
Liu, Yajie
Shi, Jiaheng
Yang, Zhu
Author_xml – sequence: 1
  givenname: Jingyu
  surname: Zhang
  fullname: Zhang, Jingyu
– sequence: 2
  givenname: Qing
  surname: Guo
  fullname: Guo, Qing
– sequence: 3
  givenname: Jiaojiao
  surname: Chen
  fullname: Chen, Jiaojiao
– sequence: 4
  givenname: Yajie
  surname: Liu
  fullname: Liu, Yajie
– sequence: 5
  givenname: Dan
  surname: Kang
  fullname: Kang, Dan
– sequence: 6
  givenname: Rumei
  surname: Xiang
  fullname: Xiang, Rumei
– sequence: 7
  givenname: Jiaheng
  surname: Shi
  fullname: Shi, Jiaheng
– sequence: 8
  givenname: Jinliang
  surname: Yang
  fullname: Yang, Jinliang
– sequence: 9
  givenname: Xiaojun
  surname: Tang
  fullname: Tang, Xiaojun
– sequence: 10
  givenname: Yuxian
  surname: Nie
  fullname: Nie, Yuxian
– sequence: 11
  givenname: Jingfu
  surname: Qiu
  fullname: Qiu, Jingfu
– sequence: 12
  givenname: Xu
  surname: Wang
  fullname: Wang, Xu
– sequence: 13
  givenname: Zhu
  surname: Yang
  fullname: Yang, Zhu
– sequence: 14
  givenname: Jie
  surname: Liu
  fullname: Liu, Jie
– sequence: 15
  givenname: Qiuling
  surname: Shi
  fullname: Shi, Qiuling
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39472836$$D View this record in MEDLINE/PubMed
BookMark eNptkstu1DAUhiNURC_wAiyQJTZsUnxNbDZoNOJSqRIbWFu-nMx4lMTB8bTMC_DceDqldCrkha3j73zWsf7z6mSMI1TVa4IvCZHN-5lQKVWNKa8pFkTW4ll1RnhLasqFPHl0Pq3O53mDMWmloC-qU6Z4SyVrzqrfixFBDy6nOAaHJpMDjLlOMMWUwaO4zS4OgObdMOU4oKFgOaYPKK8BLddhhBkQ_JoglT4H6DbkNUpmCh55uIE-TkPxodghgxIYv6tzrFfxqe9l9bwz_Qyv7veL6sfnT9-XX-vrb1-ulovr2gkict251nHBCaYGc-w7ZoRQkrdYWOXAe2epapzxljaic8TJzoGU1EoDzCqw7KK6Onh9NBs9pTCYtNPRBH1XiGmlTcrB9aAJ8apVTAncWN5Ia7kUwnmnWso6S3xxfTy4pq0dwLsyZzL9kfT4ZgxrvYo3xSwoboQshnf3hhR_bmHOegizg743I8TtrBmhtGENwaqgb5-gm7hNY_mrPdVwIhhh_6iVKROEsYvlYbeX6oUknCjC2j11-R-qLA9DcCVjXSj1o4Y3jyd9GPFvjApAD4BLcZ4TdA8IwXqfVX3Iqi5Z1XdZ1YL9AV3q3W0
Cites_doi 10.1200/JCO.2013.53.4495
10.1001/jamaoncol.2015.4719
10.1038/s41591-020-01178-5
10.1136/gutjnl-2020-320891
10.1111/jgs.17816
10.2147/PPA.S307814
10.1016/j.jmii.2020.05.001
10.7326/M20-6976
10.1016/j.idc.2022.11.001
10.1016/j.tmaid.2020.101623
10.6004/jnccn.2019.0038
10.1016/S0140-6736(22)00838-8
10.1186/s12939-020-01254-9
10.1177/0333102420965157
10.1056/NEJMoa2002032
10.1186/1477-7525-4-79
10.2196/28915
10.1016/j.micpath.2020.104390
10.1200/JCO.21.01344
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12889-024-20518-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Engineering Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1471-2458
EndPage 11
ExternalDocumentID oai_doaj_org_article_11d97939506b468bb4855cdc9723fb1d
PMC11520658
A814191373
39472836
10_1186_s12889_024_20518_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Science and Technology Innovation Key R&D Program of Chongging
  grantid: No. CSTB2022TIAD-STX0013
– fundername: Fundamental Research Funds for the Central public welfare research institutes
  grantid: NO. ZZ15-WT-05
– fundername: The Postdoctoral Fellowship Program of CPSF
  grantid: GZC20233357
GroupedDBID ---
0R~
23N
2WC
2XV
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
PMFND
3V.
7T2
7XB
8FK
AZQEC
C1K
COVID
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c515t-fc7c454102a040df3a55984705b9ceddcb296cadb265fc1c8fce882b8ae3b9eb3
IEDL.DBID M48
ISSN 1471-2458
IngestDate Wed Aug 27 01:03:50 EDT 2025
Thu Aug 21 18:44:08 EDT 2025
Fri Jul 11 03:20:32 EDT 2025
Fri Jul 25 18:55:17 EDT 2025
Tue Jun 17 22:02:12 EDT 2025
Tue Jun 10 21:11:12 EDT 2025
Mon Jul 21 06:04:53 EDT 2025
Tue Jul 01 02:14:10 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Electronic Patient-Reported Outcome
Symptom
Electronic platform
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-fc7c454102a040df3a55984705b9ceddcb296cadb265fc1c8fce882b8ae3b9eb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12889-024-20518-5
PMID 39472836
PQID 3126415313
PQPubID 44782
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_11d97939506b468bb4855cdc9723fb1d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11520658
proquest_miscellaneous_3122636109
proquest_journals_3126415313
gale_infotracmisc_A814191373
gale_infotracacademiconefile_A814191373
pubmed_primary_39472836
crossref_primary_10_1186_s12889_024_20518_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-10-29
PublicationDateYYYYMMDD 2024-10-29
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-29
  day: 29
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC public health
PublicationTitleAlternate BMC Public Health
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References AJ Rodriguez-Morales (20518_CR2) 2020; 34
Q Shi (20518_CR14) 2021; 27
Y Song (20518_CR6) 2020; 69
Guidance for industry (20518_CR10) 2006; 4
20518_CR17
20518_CR18
20518_CR15
20518_CR13
E Caronna (20518_CR5) 2020; 40
H Yu (20518_CR12) 2021; 23
WJ Guan (20518_CR4) 2020; 382
20518_CR1
20518_CR19
Y Abul (20518_CR22) 2023; 37
A Pormohammad (20518_CR3) 2020; 147
E Basch (20518_CR24) 2016; 2
DP Oran (20518_CR7) 2021; 174
CY Jung (20518_CR8) 2020; 99
RA Swarm (20518_CR21) 2019; 17
EM Goldberg (20518_CR23) 2022; 70
Y Feng (20518_CR25) 2021; 15
LL Lau (20518_CR9) 2020; 19
W Dai (20518_CR11) 2022; 40
X Zhang (20518_CR16) 2022; 399
JE Bower (20518_CR20) 2014; 32
References_xml – volume: 32
  start-page: 1840
  issue: 17
  year: 2014
  ident: 20518_CR20
  publication-title: J Clin oncology: official J Am Soc Clin Oncol
  doi: 10.1200/JCO.2013.53.4495
– volume: 2
  start-page: 433
  issue: 4
  year: 2016
  ident: 20518_CR24
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2015.4719
– volume: 27
  start-page: 86
  issue: 1
  year: 2021
  ident: 20518_CR14
  publication-title: Nat Med
  doi: 10.1038/s41591-020-01178-5
– volume: 69
  start-page: 1143
  issue: 6
  year: 2020
  ident: 20518_CR6
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-320891
– ident: 20518_CR1
– volume: 70
  start-page: 1918
  issue: 7
  year: 2022
  ident: 20518_CR23
  publication-title: J Am Geriatr Soc
  doi: 10.1111/jgs.17816
– volume: 15
  start-page: 1101
  year: 2021
  ident: 20518_CR25
  publication-title: Patient Prefer Adherence
  doi: 10.2147/PPA.S307814
– ident: 20518_CR19
  doi: 10.1016/j.jmii.2020.05.001
– ident: 20518_CR18
– volume: 174
  start-page: 655
  issue: 5
  year: 2021
  ident: 20518_CR7
  publication-title: Ann Intern Med
  doi: 10.7326/M20-6976
– volume: 99
  start-page: 266
  year: 2020
  ident: 20518_CR8
  publication-title: Int J Infect diseases: IJID : official publication Int Soc Infect Dis
– volume: 37
  start-page: 1
  issue: 1
  year: 2023
  ident: 20518_CR22
  publication-title: Infect Dis Clin North Am
  doi: 10.1016/j.idc.2022.11.001
– volume: 34
  start-page: 101623
  year: 2020
  ident: 20518_CR2
  publication-title: Travel Med Infect Dis
  doi: 10.1016/j.tmaid.2020.101623
– volume: 17
  start-page: 977
  issue: 8
  year: 2019
  ident: 20518_CR21
  publication-title: J Natl Compr Canc Netw
  doi: 10.6004/jnccn.2019.0038
– volume: 399
  start-page: 2011
  issue: 10340
  year: 2022
  ident: 20518_CR16
  publication-title: Lancet (London England)
  doi: 10.1016/S0140-6736(22)00838-8
– ident: 20518_CR15
– volume: 19
  start-page: 137
  issue: 1
  year: 2020
  ident: 20518_CR9
  publication-title: Int J Equity Health
  doi: 10.1186/s12939-020-01254-9
– volume: 40
  start-page: 1410
  issue: 13
  year: 2020
  ident: 20518_CR5
  publication-title: Cephalalgia: Int J headache
  doi: 10.1177/0333102420965157
– ident: 20518_CR13
– ident: 20518_CR17
– volume: 382
  start-page: 1708
  issue: 18
  year: 2020
  ident: 20518_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2002032
– volume: 4
  start-page: 79
  year: 2006
  ident: 20518_CR10
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-4-79
– volume: 23
  start-page: e28915
  issue: 11
  year: 2021
  ident: 20518_CR12
  publication-title: J Med Internet Res
  doi: 10.2196/28915
– volume: 147
  start-page: 104390
  year: 2020
  ident: 20518_CR3
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2020.104390
– volume: 40
  start-page: 988
  issue: 9
  year: 2022
  ident: 20518_CR11
  publication-title: J Clin oncology: official J Am Soc Clin Oncol
  doi: 10.1200/JCO.21.01344
SSID ssj0017852
Score 2.4234762
Snippet Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases and...
Background Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases...
BackgroundMonitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing severe cases...
Abstract Background Monitoring symptoms is crucial for the early detection of disease progression and timely intervention, which is essential for reducing...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2989
SubjectTerms Adolescent
Adult
Appetite loss
Asymptomatic
Cancer surgery
Care and treatment
China
Clinical outcomes
Communicable diseases
Coronaviruses
Cough
COVID-19
COVID-19 - diagnosis
COVID-19 - epidemiology
Data base management systems
Data collection
Data entry
Data storage
Data transmission
Development and progression
Disease transmission
Early experience
Electronic Patient-Reported Outcome
Electronic platform
Electronic systems
Encryption
Epidemics
Feasibility
Female
Health aspects
Humans
Infectious diseases
Information storage and retrieval
Literature reviews
Lung cancer
Male
Medical research
Medicine, Experimental
Middle Aged
Monitoring
Mortality
Pandemics
Patient outcomes
Patient Reported Outcome Measures
Patients
Project design
Project management
Public health
Quality of life
Questionnaires
Real time
Respiratory diseases
SARS-CoV-2
Sensitivity analysis
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Sleep disorders
Smartphones
Sputum
Symptom
Symptom Assessment - methods
Symptom management
Telemedicine
Viral diseases
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07j9QwELbQVUgI8SZwICMhUSDr1s_YdAvidEKCipOus_yEKzZZ7WaL-wP8bsZxdm8DBQ1t7ESJ5xvPZ2f8DUJvnWA5Gp8IX7BMhIqZOG8YYYHpHBxXPJfDyV-_qYtL8eVKXh2V-io5YVUeuA7cGaXRAIaMXCgvlPa-qJmEGEq1rOxpLLMvxLz9Ymr6f9BqyfZHZLQ628IsXFKDmABUSKqJnIWhUa3_7zn5KCjNEyaPItD5A3R_oo54WV_5IbqTukfoXt13w_U40WP0a9nh29I2eJJNJfXXQIq43w2AsYS3N6v10K_wavTpzQcMRBCXYtppm3A66B_jsk-LN259HXG8zS_CfcYOA9-MN2ToyY_-z-c9QZfnn79_uiBTrQUSgNEMJIc2CCmAbjhw65i5K8rtol1Ib0KKMXhmVHDRMyVzoAEMmYCce-0S9wZW5E_RSdd36TnCNHBDYw6LCNyBc2aozCZLZTT3qW1jg97vh96uq6SGHZciWtlqKAuGsqOhrGzQx2KdQ88ihz1eAJDYCST2XyBp0LtiW1ucFgwY3HT2AF64yF_ZpaYCFq685Q06nfUEZwvz5j067OTsW8spsEqIHBSa3xyay50lga1L_W7swxQv2vYNelbBdPgkbkQLLE81SM9gNvvmeUt3_XOUAgc-zwqJfPE_RuklusuKi0BkZuYUnQybXXoFlGvwr0fv-g1odysy
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Public Health Database
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXJAQ4t20BRkJiQOyurEdJ-aCloqqQoITlXqz_Cw9bLJssof-AX43M0k224DENXYezrw-2-NvCHlnJU9Bu8jEgicmVUjMOs0Z97xK3golEh5O_vZdXVzKr1fF1bjg1o5plTuf2Dvq0HhcIz8VOYRuMM9cfFr_Ylg1CndXxxIa98mDHHwwcudXZ1OKBxae57uDMpU6bcEXY4IQl6AbRV6xYhaMes7-fz3zndA0T5u8E4fOn5DHI4Cky0HiT8m9WD8jj4bVNzocKnpOfi9rui9wQ0fyVDZsEMRAm20Ho460vV2tu2ZFV71lbz5SgIMUS2rHNtI4sSBTXK2lG7u-CTTss4xok6ilgDrDLesadt38_bwX5PL8y4-zCzZWXGAecE3Hki-9LCSADgvGHZKwyN8uy0XhtI8heMe18jY4rorkcw_ijADRXWWjcBrm5S_JQd3U8ZDQ3Audh-QXAeQiBNd5kXQqlK6Ei2UZMvJh9-vNeiDWMP2EpFJmEJQBQZleUKbIyGeUztQTSbH7C83m2ow2BvcGDe5GFwvlpKqcQ-IbHzwWVksuh1e-R9kaNF0QoLfjCQT4YCTBMssqlzB9FaXIyMmsJ5icnzfvtMOMJt-avYJm5O3UjHdiGlsdm23fhyuBDPcZeTUo0zQkoWUJWE9lpJqp2WzM85b65mdPCA6oniOUPPr_dx2ThxyVHyIv1yfkoNts42uAVJ1709vNH0XGIuU
  priority: 102
  providerName: ProQuest
Title An electronic patient-reported outcome symptom monitor: the Chinese experience with rapid development of a ready-to-go symptom monitor
URI https://www.ncbi.nlm.nih.gov/pubmed/39472836
https://www.proquest.com/docview/3126415313
https://www.proquest.com/docview/3122636109
https://pubmed.ncbi.nlm.nih.gov/PMC11520658
https://doaj.org/article/11d97939506b468bb4855cdc9723fb1d
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bixMxFA57eRFEvG91LREEHyTaXCaTCCLtsnURdpHFQvFlmNzWBTtT2ynYP-Dv9mRm2u7ovviSh0kyM8k5J-fL7TsIvcoFC04bT_iABSKkCyQ3mhFmmQo255KHeDn5_EKeTcTnaTLdQ5twR20HLm-d2sV4UpPFj7e_fq4_gsF_qA1eyXdLGGPjwR8mQOYJVSTZR4fgmdIYyuFc7HYVUlVH4KEwIBMmErW5RHPrOzqOqubz_3fUvuG2ukcqb_io8X10rwWXeNhowwO054uH6G6zMoebC0eP0O9hgXfBb3BLrEqazQPvcLmqQAs9Xq5n86qc4Vlt9Yv3GKAijuG2_dJjv2VIxnElFy_y-bXDbncCCZcB5xgQqVuTqiRX5d_ve4wm49OvJ2ekjcZALGCeigSbWpEIACQ5GL4LPI_c7iIdJEZb75w1TEubO8NkEiy1IGoP8N2o3HOjYc7-BB0UZeGPEKaWa-qCHThAF5wzTZOgQyK14sanqeuhN5uuz-YN6UZWT1aUzBpBZSCorBZUlvTQKEpnWzISZtcPysVV1tof1HUahiKdDKQRUhkTSXGsszHoWjAUPvk6yjaLigYCtHl7OwF-OBJkZUNFBUxtecp76LhTEszRdrM32pFttDnjFHAn-BYK2S-32bFmPOJW-HJVl2GSR_b7HnraKNO2SVyLFHCg7CHVUbNOm7s5xfX3miwcED-LMPPZf_Xpc3SHRVsAJ830MTqoFiv_AtBXZfpoP52mkKoTGtPxpz46HJ1efLns1-sZ_drkIL0cffsDp1QyWg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOYCEEM8SKGAkEAdkdWMnToyE0FKoWvo4tVJvJn6VHjZZdrNC-wf4OfxGZvLYbUDi1mvsJHbm7cx8Q8jrIuHBKeOZGPHAEukCK4zijFueB1sIKQIWJx-fyP2z5Ot5er5Bfve1MJhW2evERlG7yuIZ-Y6IwXSDeMbi4_QHw65R-He1b6HRssWhX_6EkG3-4eAz0PcN53tfTnf3WddVgFmw3TULNrNJmoBhLYCBXRAFYpQn2Sg1ynrnrOFK2sIZLtNgYwtL9uCGmrzwwiiIPeG5N8jNRIgMsfrz3VVKCTa6531hTi535qD7MSGJJ8CLaZyzdGD8mh4B_1qCK6ZwmKZ5xe7t3SN3O4eVjlsOu082fPmA3GlP-2hbxPSQ_BqXdN1Qh3Zgraz9IeEdrRY1fGVP58vJtK4mdNJoktl7Cu4nxRbefu6pX6EuUzwdprNieumoW2c10SrQgoKX65asrthF9ffzHpGza6HFY7JZVqV_QmhshYpdsCMHHosQXMVpUCGVKhfGZ5mLyLv-0-tpC-ShmwAol7ollAZC6YZQOo3IJ6TOaiaCcDcXqtmF7mQa7nUK1JtKR9IkMjcGgXass9jILZgYXvkWaatRVQABbdFVPMCCEXRLj_M4gXBZZCIi24OZIOJ2ONxzh-5UzFyvBSIir1bDeCemzZW-WjRzuBSIqB-RrZaZVlsSKsnAt5QRyQdsNtjzcKS8_N4AkEMUwdF1ffr_db0kt_ZPj4_00cHJ4TNym6MggNXnapts1rOFfw7uXG1eNDJEybfrFto_oTRh0w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+electronic+patient-reported+outcome+symptom+monitor%3A+the+Chinese+experience+with+rapid+development+of+a+ready-to-go+symptom+monitor&rft.jtitle=BMC+public+health&rft.au=Zhang%2C+Jingyu&rft.au=Guo%2C+Qing&rft.au=Chen%2C+Jiaojiao&rft.au=Liu%2C+Yajie&rft.date=2024-10-29&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12889-024-20518-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12889_024_20518_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon